CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 46 enrolled
Drug / intervention
Simvastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03400475
NCT03400475Phase 2Completed

The Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis: A Pilot Study

Ahmed Mohamed Mahrous·interventional·Posted Jan 17, 2018·Updated Dec 19, 2018

In Brief

A Phase 2 clinical trial evaluating Simvastatin and Placebo for Peri-implant Mucositis. Completed, enrolled 46 participants across 1 site.

Detailed Summary

This study seeks to test the recently discovered anti-inflammatory action of statins on inflamed mucosa surrounding dental implants. Hypothesis: The application of 1.2% simvastatin gel will decrease peri-implant inflammation. The pilot study will involve 44 subjects divided into a test and control group. The test group shall receive topical simvastatin gel administered around the implant with a blunt tipped needle. The control group will receive a placebo. Inflammatory state shall be determined at baseline as well as follow up visits at 24 hours, 1 week, and 1 month by clinical indices of inflammation as well as biochemical markers of inflammation gathered from around the implants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 17, 2018
Enrollment StartApr 23, 2015
Primary CompletionOct 24, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.5 years ago

Interventions

Simvastatindrug

One topical application in peri-implant gingival crevice

Placeboother

One topical application in peri-implant gingival crevice